Octozi Raises $3M in Seed Funding to bring Agentic AI to Clinical Development
New York City, United States, July 7th, 2026, FinanceWire Octozi, an artificial intelligence company that automates clinical development workflows for pharmaceutical sponsors, has raised $3 million in seed funding. The round was led by Surface Ventures, with participation from Remarkable Ventures, and follows a prior investment from the venture arm of Debiopharm, a Swiss pharmaceutical […]



















